Hand Foot and Mouth

In an exclusive interview with Benzinga, director of Investor Relations, Helen Yang, discussed Sinovac’s (NASDAQ: SVA) future opportunities. Sinovac is Chinese biopharmaceutical company which produces, among others, a hepatitis A and B vaccine and is currently preparing to commercialize...